Related Experiment Video
Updated: Apr 30, 2026

Characterization of Intra-Cartilage Transport Properties of Cationic Peptide Carriers
Published on: August 10, 2020
Development of Artocarpin-Loaded Chitosan Particles for Controlled Release and Inflammatory Application
Piyapan Manklinniam1, Phonchanok Reuk-Ngam2, Supavadee Boontha3
1Division of Microbiology and Parasitology, School of Medical Sciences, University of Phayao, Phayao 56000, Thailand.
This study developed artocarpin-loaded chitosan microparticles (CSPs/AE) for enhanced anti-inflammatory delivery. The novel system demonstrated significant nitric oxide reduction, showing potential for osteoarthritis management.
Area of Science:
- Pharmacology and Drug Delivery
- Natural Product Chemistry
- Materials Science
Background:
- Artocarpin, a flavonoid from *Artocarpus altilis*, exhibits anti-inflammatory and geroprotective properties.
- Enhancing artocarpin's stability and efficacy requires advanced delivery systems.
- Chitosan microparticles offer a biocompatible platform for drug delivery.
Purpose of the Study:
- To isolate and characterize artocarpin from *Artocarpus altilis* heartwood.
- To develop and optimize chitosan-based microparticles for artocarpin delivery.
- To evaluate the physicochemical properties, in vitro release, and anti-inflammatory activity of the artocarpin-loaded microparticles.
Main Methods:
- Artocarpin isolation via maceration and chromatographic purification.
- Chitosan microparticle formulation using sodium tripolyphosphate cross-linking.
- Characterization using HPLC, DLS, FTIR, XRD, and in vitro release studies.
- Assessment of anti-inflammatory activity via nitric oxide inhibition in LPS-stimulated RAW 264.7 macrophages.
Main Results:
- Isolated artocarpin with 81% purity; developed stable chitosan microparticles (1-4 µm) with good encapsulation efficiency.
- FTIR and XRD confirmed successful artocarpin incorporation into the chitosan matrix.
- In vitro studies showed biphasic release and significant, dose-dependent reduction in nitric oxide production (34.33-73.19%).
Conclusions:
- Artocarpin-loaded chitosan microparticles (CSPs/AE) represent a promising delivery system for artocarpin.
- The developed system exhibits effective anti-inflammatory properties.
- This formulation holds potential for managing inflammatory conditions like osteoarthritis.
More Related Videos
Related Concept Videos
Modified-Release Drug Delivery Systems: Stimuli-Activated
Modified-Release Drug Delivery Systems: Site-Targeted
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Oral Drug Delivery Systems: Delayed-Release Systems

